About us
You are here: Home \ About us

CDMS has been founded in 2005 with focus on early stage clinical trials (Phase I-II) and non-interventional studies (NIS)

from Phase I to Phase IIa and Phase IV and Post-marketing follow-through.

CDMS supports your project from its initiation to its completion, ensuring compliance with all applicable laws and regulations throughout the process. We assist with clinical trial applications, maintenance and regulatory trial support.

During the last years, post-authorisation safety studies (PASS) or post authorization efficacy studies (PAES) and non-interventional studies (NIS) have become more and more important in recent years. CDMS provides highly attractive and competitive offers planning and performing NIS.

Reinhard Riedlsperger

Reinhard Riedlsperger has studied biology at the Universities of Graz and Salzburg and graduated to Mag. rer. nat. at the Institute of Zoology. Reinhard Riedlsperger is working in the pharmaceutical industry in the field of clinical research since 1996. He was responsible for the management and monitoring of several national and international phase I to phase IV studies. He is experienced in Data Management and Biometrical Analysis. In 2004 he founded the CRS Riedlsperger KG – Clinical Research Services, a CRO providing multiple services in clinical research with focus on oncology studies.

Beside the clinical project management and monitoring, Reinhard Riedlsperger is experienced in Quality Assurance Management, specifically in the development and implementation of SOPs and in performing Site Audits. Further fields of experience include scientific writing, training of personnel as well as initial and ongoing submission of study documents to Ethics Committees and Authorities.

He is author and co-author of several publications in the field of zoology.

Andreas Obwaller

Andreas Obwaller has studied biology at the University of Vienna and graduated to Mag. rer. nat. at the Clinical Institute of Hygiene at the Medical University Vienna. After studies at the Dept. of Pathophysiology and the Clinical Institute of Hygiene at the Medical University Vienna he graduated to PhD. Andreas Obwaller has more than 7 years experience in academic research in the field of parasitology and three years experience in cancer research in a commercial company. Since 2001 he is working in the pharmaceutical industry as project manager, founder of a drug development company and head of preclinical development in a mid size pharmaceutical company.

He is a member of several national and international scientific associations and author or co-author of numerous original papers, patents and book chapters in the field of parasitology and cancer therapy and presented communications at various international conferences.

Norbert Eller

Norbert Eller studied Molecular Biology at the University of Vienna and graduated to PhD at the Institute of Genetics and Microbiology. Norbert Eller has 5 years experience in the field of gene transfer and cell cycle control. Since 1994 he is working in the pharmaceutical industry as clinical project manager and consultant for Drug Development and Clinical Research. He was responsible for the management of several pivotal phase III studies including the coordination of drug approval procedures in Europe. He is experienced in Data Management and Biometrical Analysis. As consultant he is involved in the development of “Drug Development Plans” for new substances in the field Oncology, Pain and Inflammation. Furthermore Norbert Eller has experience as Product Manager und Sales Representative for Oncology.

Beside the clinical project management, Norbert Eller was responsible for the development of SOPs for different pharmaceutical companies and organized Data Management Departments including Scientific Writing.

He is author or co-autor of several publications in the fields pain, inflammation, hormonal therapy and oncology.